
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | -- | -- | -- | $1.89 | -- |
08/08/2025 | Q2 | -- | -- | -- | $0.85 | -- |
05/08/2025 | Q1 | $980.2M | $1B | -$1.38 | $1.61 | -$2.99 |
12/31/2024 | Q4 | $1B | $569.8M | $1.04 | $3.45 | -$2.41 |
09/30/2024 | Q3 | $554M | $549.6M | $3.22 | $3.17 | $0.05 |
06/30/2024 | Q2 | $429.9M | $487M | $1.96 | $0.94 | $1.02 |
03/31/2024 | Q1 | $516.9M | $546.7M | $3.39 | $2.54 | $0.85 |
12/31/2023 | Q4 | $608.9M | $634.3M | $5.05 | $5.60 | -$0.55 |
09/30/2023 | Q3 | $587.3M | $540.7M | $3.11 | $4.80 | -$1.69 |
06/30/2023 | Q2 | $588.3M | $654M | $4.94 | $4.66 | $0.28 |
03/31/2023 | Q1 | $592.8M | $677.6M | $6.55 | $5.04 | $1.51 |
12/31/2022 | Q4 | -- | $608.9M | $5.39 | -- | -- |
09/30/2022 | Q3 | -- | $530M | $4.25 | -- | -- |
06/30/2022 | Q2 | -- | $604.9M | $3.54 | -- | -- |
03/31/2022 | Q1 | -- | $536.2M | -$0.13 | -- | -- |
12/31/2021 | Q4 | -- | $335M | $3.30 | -- | -- |
09/30/2021 | Q3 | -- | $292M | -$3.30 | -- | -- |
06/30/2021 | Q2 | -- | $303.2M | $0.12 | -- | -- |
03/31/2021 | Q1 | -- | $330.8M | $0.75 | -- | -- |
12/31/2020 | Q4 | -- | $268.8M | $0.49 | -- | -- |
09/30/2020 | Q3 | -- | $214.3M | -$0.28 | -- | -- |
06/30/2020 | Q2 | -- | $121.3M | -$0.69 | -- | -- |
03/31/2020 | Q1 | -- | $275.1M | $0.09 | -- | -- |
12/31/2019 | Q4 | -- | $326M | $0.54 | -- | -- |
09/30/2019 | Q3 | -- | $321.4M | $0.16 | -- | -- |
06/30/2019 | Q2 | -- | $371.2M | $1.56 | -- | -- |
03/31/2019 | Q1 | -- | $357M | $0.52 | -- | -- |
12/31/2018 | Q4 | -- | $370.5M | $1.41 | -- | -- |
09/30/2018 | Q3 | -- | $313.4M | $0.20 | -- | -- |
06/30/2018 | Q2 | -- | $404.8M | $1.58 | -- | -- |
03/31/2018 | Q1 | -- | $384.1M | $2.20 | -- | -- |
12/31/2017 | Q4 | -- | $327.4M | -$1.04 | -- | -- |
09/30/2017 | Q3 | -- | $316.1M | $0.28 | -- | -- |
06/30/2017 | Q2 | -- | $336.3M | $1.71 | -- | -- |
03/31/2017 | Q1 | -- | $341.6M | $1.46 | -- | -- |
12/31/2016 | Q4 | -- | $344.8M | $0.66 | -- | -- |
09/30/2016 | Q3 | -- | $281.6M | $0.09 | -- | -- |
06/30/2016 | Q2 | -- | $270.1M | $0.45 | -- | -- |
03/31/2016 | Q1 | -- | $247M | $0.28 | -- | -- |
Core Natural Resources reported $1B worth of top line sales in its most recent quarter.
Core Natural Resources announced earnings per share of -$1.38 which represents a miss of analyst forecast a $1.61 per share.
Core Natural Resources reported -- that represents -- per share over the last quarter.
Core Natural Resources's earnings are forecast to grow from $9.61 per share to $11.50 per share next year representing an increase of 0.42%.
Core Natural Resources's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.